Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐16 weeks) compared with CBT (low certainty).
It is very uncertain whether behavioural activation changes treatment acceptabilityup to 6 months (4‐12 weeks) compared with interpersonal, cognitive analytic, integrative (very low certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (1 to 10 weeks) compared with waiting list (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (16 weeks) compared with placebo (low certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (12‐16 weeks) compared with medication (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (2‐5 weeks) compared with no treatment (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptabilityup to 6 months (5‐12 weeks) compared with treatment (moderate certainty).
Behavioural activation showed no clear difference in treatment acceptability up to 6 months (4‐8 weeks) compared with third‐wave CBT (low certainty).
Behavioural activation showed no clear difference in treatment acceptability (short term: 2 months) compared with any comparator (low certainty).
Antidepressants plus benzodiazepines showed no clear difference in acceptability of treatment (dropout for any reason) compared with antidepressants alone (moderate certainty).
Vaginal misoprostol showed no clear difference in woman’s satisfaction/acceptability of method compared with surgical evacuation of uterus (low certainty).
Vaginal misoprostol showed no clear difference in woman’s satisfaction/acceptability of method compared with placebo (low certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with valproate (high certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with lamotrigine (very low certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with carbamazepine (low certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with quetiapine (very low certainty).
Lithium may leads to higher acceptability: total withdrawals compared with olanzapine (low certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with placebo (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with chlorpromazine (low certainty).